Thymosin beta4 has tumor suppressive effects and its decreased expression results in poor prognosis and decreased survival in multiple myeloma.

Abstract : Thymosin beta4 (Tbeta4) is a polypeptide involved in cellular proliferation, differentiation, and migration, over-expressed in several tumor entities. We evaluated its expression and function in 298 newly diagnosed multiple myeloma patients and the murine 5TMM model. Mean Tbeta4 expression was significantly lower in myeloma cells compared to normal plasma cells (P<0.001). The same observation can be made in the 5TMM-mouse model by qRT-PCR and ELISA. Here, Tbeta4 overexpression by lentiviral transduction of 5T33MMvt-cells led to significantly decreased proliferative and migratory capacities and increased sensitivity to apoptosis-induction. Mice injected with Tbeta4 over-expressing myeloma cells showed a longer survival compared to mice injected with controls (88,9 vs. 65,9 days, P<0.05). In 209 MM patients treated with high-dose therapy and autologous stem cell transplantation, expression of Tbeta4 below the median was associated with a significantly shorter event free survival (37.6 vs. 26.2 months, P<0.05). In conclusion, our results indicate a possible tumor suppressive function of Tbeta4.
Type de document :
Article dans une revue
Haematologica, Ferrata Storti Foundation, 2010, 95 (1), pp.163-7. 〈10.3324/haematol.2009.006411〉
Liste complète des métadonnées

Littérature citée [17 références]  Voir  Masquer  Télécharger

http://www.hal.inserm.fr/inserm-00453267
Contributeur : Monique Frei <>
Soumis le : jeudi 4 février 2010 - 11:28:53
Dernière modification le : vendredi 20 octobre 2017 - 01:17:30
Document(s) archivé(s) le : vendredi 18 juin 2010 - 18:49:48

Fichiers

2010_1Haematologica0307.pdf
Fichiers produits par l'(les) auteur(s)

Identifiants

Collections

Citation

Jo Caers, Dirk Hose, Ine Kuipers, Tomas Jan Bos, Els Van Valckenborgh, et al.. Thymosin beta4 has tumor suppressive effects and its decreased expression results in poor prognosis and decreased survival in multiple myeloma.. Haematologica, Ferrata Storti Foundation, 2010, 95 (1), pp.163-7. 〈10.3324/haematol.2009.006411〉. 〈inserm-00453267〉

Partager

Métriques

Consultations de la notice

204

Téléchargements de fichiers

368